家族性原发性甲状旁腺功能亢进患者基因检测阳性的概率
本研究回顾性分析657例因原发性甲状旁腺功能亢进(PHPT)行首次甲状旁腺切除术的患者,其中205例(31.2%)有家族史。在205例有家族史患者中,123例(60%)检出种系突变(91例MEN1、14例CDC73、18例GCM2)。多因素分析显示年龄≤45岁、男性和多腺体病变是与基因检测阳性独立相关的因素。
要点
- 有家族史的PHPT患者中60%可检出种系突变。
- 年龄≤45岁、男性、多腺体病变提示基因检测阳性。
- 有家族史者初次手术后生化治愈率较低(89.2% vs 96.2%)。
核心结论
- 除家族史外,男性、年龄≤45岁和多腺体病变应促使医生提供遗传咨询和检测,因其可能影响PHPT患者的管理。
研究设计与样本
- 回顾性分析657例在三级转诊中心因PHPT行首次甲状旁腺切除术的患者,其中205例有家族史者纳入logistic回归分析。
主要发现
- 657例中205例(31.2%)有家族史;205例中123例(60%)检出种系突变(91例MEN1、14例CDC73、18例GCM2)。
- 单因素分析中,年龄≤45岁、男性、多腺体病变和甲状旁腺癌与种系突变阳性相关。
- 有家族史者初次甲状旁腺切除术后生化治愈率较低(96.2% vs 89.2%;p=0.005)。
- 多因素分析中,年龄≤45岁、男性和多腺体病变是基因检测阳性的独立相关因素。
临床怎么用
- 对PHPT患者应询问家族史,对有家族史且具备男性、年龄≤45岁或多腺体病变者建议遗传咨询和检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Approximately 10% of patients with primary hyperparathyroidism (PHPT) have hereditary disease. Hereditary PHPT may be syndromic (MEN1, 2, and 4 and hyperparathyroidism-jaw tumor syndrome) or non-syndromic (familial isolated PHPT). There are limited data on the probability of testing positive for genetic mutation based on clinical presentation. The aim of this study was to determine potential associations between clinical and biochemical features and mutation in susceptibility genes for PHPT in patients with a family history of PHPT. STUDY DESIGN: A retrospective analysis of 657 patients who had an initial parathyroidectomy for PHPT at a tertiary referral center. Logistic regression analyses were performed in 205 patients with a family history of PHPT to identify factors associated with a positive genetic test. RESULTS: Of 657 patients, 205 (31.2%) had a family history of PHPT. Of those 205 patients, 123 (60%) had a germline mutation detected (91 MEN1, 14 CDC73, and 18 GCM2). In univariate analysis, younger age (45 years and younger), male sex, multigland disease, and parathyroid carcinoma were associated with positive germline mutation; biochemical cure after an initial parathyroidectomy was less frequent in patients with familial PHPT (96.2% vs 89.2%; p = 0.005). In multivariable analysis, age 45 years and younger, male sex, and multigland disease were independent factors associated with positive genetic testing. CONCLUSIONS: In addition to a family history of PHPT, male sex, age 45 years and younger, and presence of multigland disease, should prompt physicians to offer the opportunity for genetic counseling and testing, as it could influence the management of patients with PHPT.
引用
- El Lakis M, Nockel P, Gaitanidis A, et al. Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism. J Am Coll Surg. 2018. PMID: 29408534. doi:10.1016/j.jamcollsurg.2018.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。